首页 > 市场调查报告书 > 製药

呼吸器

全球咳嗽过敏综合症治疗市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

市场调查报告书

商品编码

1342888

全球咳嗽过敏综合症治疗市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Cough Hypersensitivity Syndrome Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 155 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

预计到 2030 年，全球咳嗽过敏综合症治疗市场的市场规模将从 2022 年的 103.3 亿美元达到近 200 亿美元，2023-2030 年研究期间复合年增长率为 7.62%。

众所周知，咳嗽过敏综合症会影响具有某些特定类型咳嗽症状的人。咳嗽对患者生活的严重影响是睡眠中断、呕吐、头晕、肋骨骨折、胃食管反流病和感染。

市场动态：

由于全球慢性呼吸道疾病的增加，咳嗽过敏综合症市场的增长正在上升。此外，吸烟人数也大幅上升。吸烟是许多人咳嗽的主要原因。因此，这一因素进一步导致市场扩张。推动咳嗽过敏综合症市场增长的其他一些因素包括有助于控制咳嗽的药物输送系统的技术发展以及对咳嗽多剂量的需求增加。此外，由于慢性胃食管反流病（GERD）患病率不断上升，对咳嗽过敏综合征的需求正在扩大。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球咳嗽过敏综合征治疗市场的各个细分市场进行了包容性评估。咳嗽过敏综合征治疗行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲咳嗽过敏综合症治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。咳嗽过敏综合症治疗市场的主要参与者包括辉瑞公司、葛兰素史克公司、勃林格殷格翰公司、阿斯利康公司、罗氏公司、梯瓦製药工业有限公司、诺华公司、默克公司、Vertex Pharmaceuticals Incorporated、Johnson & Johnson Consumer Inc. 本部分包含竞争格局的整体视图，其中包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布、以及其他进展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

区域展望
介绍
北美销售分析
- 概述、历史和预测销售分析
- 北美按细分市场销售分析
- 北美按国家/地区销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家/地区销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家/地区销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：咳嗽超敏综合征治疗公司的竞争格局

咳嗽过敏综合症治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市场份额分析
市场集中度
Pfizer Inc.

公司简介
公司收入
产品
最近的发展

GlaxoSmithKline plc

公司简介
公司收入
产品
最近的发展

Boehringer Ingelheim GmbH

公司简介
公司收入
产品
最近的发展

AstraZeneca

公司简介
公司收入
产品
最近的发展

F. Hoffmann-La Roche Ltd.

公司简介
公司收入
产品
最近的发展

Teva Pharmaceutical Industries Ltd.

公司简介
公司收入
产品
最近的发展

Novartis AG

公司简介
公司收入
产品
最近的发展

Merck & Co. Inc.

公司简介
公司收入
产品
最近的发展

Vertex Pharmaceuticals Incorporated

公司简介
公司收入
产品
最近的发展

Johnson & Johnson Consumer Inc.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

简介目录图表

Product Code: VMR11219364

The global demand for Cough Hypersensitivity Syndrome Treatment Market is presumed to reach the market size of nearly USD 20 BN by 2030 from USD 10.33 BN in 2022 with a CAGR of 7.62% under the study period 2023 - 2030.

Cough hypersensitivity syndrome is known to affect people with certain specific types of cough symptoms. The severe effect of cough on patients' lives is sleep disruption, vomiting, dizziness, rib fractures, gastroesophageal reflux disease, and infections.

MARKET DYNAMICS:

The growth of the cough hypersensitivity syndrome market is rising due to increase in chronic respiratory illnesses conditions globally. In addition, a considerable rise in the number of cigarette smokers. Cigarette smoking is the primary cause of cough in many people. Thus, this factor is further leading to market expansion. Some other factors that have fueled the growth of the cough hypersensitivity syndrome market include technological developments in drug delivery systems that aid in controlling coughing and an increase in demand for multiple dosages for cough. In addition, the need for cough hypersensitivity syndrome is expanding due to the rising prevalence of chronic gastroesophageal reflux disease (GERD).

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cough hypersensitivity syndrome treatment. The growth and trends of cough hypersensitivity syndrome treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cough hypersensitivity syndrome treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Drug Class

Antitussive Agents
Inhaled Corticosteroids
Short Acting Beta-2 Agonists
Anti-Cholinergics
Antihistamines
Proton Pump Inhibitors
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cough Hypersensitivity Syndrome Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cough hypersensitivity syndrome treatment market include Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Novartis AG, Merck & Co. Inc., Vertex Pharmaceuticals Incorporated, Johnson & Johnson Consumer Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . COUGH HYPERSENSITIVITY SYNDROME TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Drug Class
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL COUGH HYPERSENSITIVITY SYNDROME TREATMENT MARKET ANALYSIS BY DRUG CLASS

6.1 Overview by Drug Class
6.2 Historical and Forecast Data
6.3 Analysis by Drug Class
6.4 Antitussive Agents Historic and Forecast Sales by Regions
6.5 Inhaled Corticosteroids Historic and Forecast Sales by Regions
6.6 Short Acting Beta-2 Agonists Historic and Forecast Sales by Regions
6.7 Anti-cholinergics Historic and Forecast Sales by Regions
6.8 Antihistamines Historic and Forecast Sales by Regions
6.9 Proton Pump Inhibitors Historic and Forecast Sales by Regions
6.10. Others Historic and Forecast Sales by Regions

7 . GLOBAL COUGH HYPERSENSITIVITY SYNDROME TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

7.1 Overview by Distribution Channel
7.2 Historical and Forecast Data
7.3 Analysis by Distribution Channel
7.4 Hospital Pharmacies Historic and Forecast Sales by Regions
7.5 Retail Pharmacies Historic and Forecast Sales by Regions
7.6 Online Pharmacies Historic and Forecast Sales by Regions

8 . GLOBAL COUGH HYPERSENSITIVITY SYNDROME TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE COUGH HYPERSENSITIVITY SYNDROME TREATMENT COMPANIES

9.1. Cough Hypersensitivity Syndrome Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF COUGH HYPERSENSITIVITY SYNDROME TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Pfizer Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. GlaxoSmithKline plc
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Boehringer Ingelheim GmbH
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. AstraZeneca
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. F. Hoffmann-La Roche Ltd.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Teva Pharmaceutical Industries Ltd.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Novartis AG
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Merck & Co. Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Vertex Pharmaceuticals Incorporated
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Johnson & Johnson Consumer Inc.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Drug Class (USD MN)
Antitussive Agents Market Sales by Geography (USD MN)
Inhaled Corticosteroids Market Sales by Geography (USD MN)
Short Acting Beta-2 Agonists Market Sales by Geography (USD MN)
Anti-cholinergics Market Sales by Geography (USD MN)
Antihistamines Market Sales by Geography (USD MN)
Proton Pump Inhibitors Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by Distribution Channel (USD MN)
Hospital Pharmacies Market Sales by Geography (USD MN)
Retail Pharmacies Market Sales by Geography (USD MN)
Online Pharmacies Market Sales by Geography (USD MN)
Global Cough Hypersensitivity Syndrome Treatment Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Cough Hypersensitivity Syndrome Treatment Report
Market Research Process
Market Research Methodology
Global Cough Hypersensitivity Syndrome Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Drug Class
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Drug Class (USD MN)
Antitussive Agents Market Sales by Geography (USD MN)
Inhaled Corticosteroids Market Sales by Geography (USD MN)
Short Acting Beta-2 Agonists Market Sales by Geography (USD MN)
Anti-cholinergics Market Sales by Geography (USD MN)
Antihistamines Market Sales by Geography (USD MN)
Proton Pump Inhibitors Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by Distribution Channel (USD MN)
Hospital Pharmacies Market Sales by Geography (USD MN)
Retail Pharmacies Market Sales by Geography (USD MN)
Online Pharmacies Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Companies Market Share Analysis